Company intelligence / Profile preview

SOOIL Development

Yongin-si, Gyeonggi-do, South Korea

Ownership: Private
Employees: ~20
Development stage: Other

Overview

SOOIL Development is a leading global developer and manufacturer of insulin pumps, with over 40 years of experience specializing in diabetes management devices. Its Dana insulin pump line is widely used worldwide, and it maintains partnerships for automated insulin delivery solutions, including collaborations with Diabeloop for integration of their AI-driven diabetes management systems[1][2].

Therapeutic areas: Endocrinology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Diabeloop: Technical integration, global development, and commercialization for Automated insulin delivery system (Dana-i ACE pump + DBLG1 AI system) in Europe, US, Korea (Clinical status: Commercial launch in Europe (pending CE), US FDA trials, Korean regulatory submission)

Beyond the preview

Go deeper on SOOIL Development.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SOOIL Development.

Explore the full profile